Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record history now shows a newer revision label, v3.6.3, replacing the prior v3.6.2, indicating an updated revision of the page content.
    Difference
    0.0%
    Check dated 2026-07-04T13:23:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history now includes a new revision labeled v3.6.2, replacing the prior v3.6.0, indicating an update to the page's revision history.
    Difference
    0.0%
    Check dated 2026-06-27T05:41:52.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and a new record revision (v3.6.0) was added, replacing the prior revision (v3.5.5).
    Difference
    0.1%
    Check dated 2026-06-13T00:29:04.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows the latest revision tag, v3.5.5, replacing the previous v3.5.4, indicating an incremental update to the page’s interface.
    Difference
    0.0%
    Check dated 2026-06-05T21:37:56.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry 'Revision: v3.5.4' was added to the revision history, and the previous 'Revision: v3.5.3' entry was removed. This updates the history to reflect the latest site revision.
    Difference
    0.0%
    Check dated 2026-05-15T15:34:30.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The study record history now includes a newer submitted version dated 2026-04-21 and associated “more information” and results-related sections, indicating the trial’s core metadata and reporting content were updated. It replaces an earlier revision (v3.5.2) reference with the latest revision (v3.5.3), consistent with an updated ClinicalTrials.gov record version.
    Difference
    0.5%
    Check dated 2026-04-24T05:23:45.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.